Dompé
at a glance

RESEARCH, DEVELOPMENT AND PRODUCTION

Dompé is a major Italian biopharmaceutical company, engaged in research, development and the production of therapeutic solutions.

PRIMARY CARE

Prescription drugs and OTC products, dietary supplements, medical devices and cosmetics

BIOTECH

Treatment of rare diseases with no approved treatment

We conduct our research activities as part of a network of over 300 centres and universities across the world that has performed 27 clinical trials for more than 2000 patients.

Discover our research
Discover our production hub
head icon
THERAPEUTIC AREAS

Pain and inflammation, respiratory, diabetology, well-being, integration

people icon
800

Total employees

chart icon
450 MILLION

Revenues in euros (2019)

globe icon
REACH

Europe, United States, China

boxes icon
60 MILLION

Packages manufactured in 2019

productionLine icon
8

Production lines (7 synthesis, 1 biotech)

dnaBio icon
CDMO

Synthesis and biotech

certificate icon
BIOTECH APPROVALS

EMA (European Medicines Agency), Europe
FDA (Food and Drug Administration), United States

BIOTECH

We have developed the first treatment based on rhNGF (recombinant human Nerve Growth Factor) for neurotrophic keratitis, a rare eye disease previously with no approved treatment.
The marketing authorization for this treatment has been granted by some international regulatory authorities, such as the EMA and the FDA.

  • 2017

    Year of marketing authorization granted by the EMA in Europe

  • 2018

    Year of marketing authorization granted by the FDA in the United States, following the Fast Track, Breakthrough Therapy Designation and Priority Review designations

  • 2019

    Inclusion among the 40 active principles of prioritary interest for China

  • 2020

    Expected CFDA (Chinese Food and Drug Administration) marketing authorization

Discover our biotech production
HISTORY

Dompé farmaceutici is established in 1940, stemming from a pharmacological tradition dating back to the Nineteenth Century

  • 1870-1890

    Gian Antonio Dompé devotes himself to studying chemical-pharmaceutical sciences and eventually becomes a science savant.

  • 1895

    Onorato Dompé, Gian Antonio’s son, establishes the Dompé-Adami laboratory in Milan.

  • 1924

    Onorato Dompé establishes the first pharmaceutical production plant in Milan.

  • 1940

    Franco Dompé, Onorato’s son, founds Dompé farmaceutici in Milan.

Discover our full story

Dompé Farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153